Education
About Us
Working with TipRanks
Follow Us
Krystal Biotech, Inc. (KRYS)
:KRYS
Earnings Data
Report Date
Mar 02, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1.5Last Year’s EPS
1.52Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Krystal Biotech demonstrated strong financial performance with significant revenue growth and successful international expansion. However, challenges remain in achieving full market penetration and optimizing margins globally.Company Guidance
VYJUVEK Revenue Growth
Net VYJUVEK revenue for Q3 was $97.8 million, contributing to a total of over $623 million since launch. Gross margins were 96% for the quarter.
International Expansion Success
VYJUVEK launched in Germany, France, and Japan, with successful pricing negotiations in Japan. The launch in Germany saw prescriptions from over 10 centers.
FDA Label Update for VYJUVEK
The FDA approved an updated VYJUVEK label, expanding the eligible patient population to DEB patients from birth and providing dosing flexibility.
Strong Financial Position
The company ended the quarter with over $864 million in cash and investments, maintaining a strong balance sheet to support commercial and pipeline activities.
Platform Therapy Designation
The FDA granted a platform therapy designation for the HSV-1 gene delivery platform, potentially accelerating approval pathways for programs like KB801.
KRYS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
KRYS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 03, 2025 | $197.51 | $197.85 | +0.17% |
Aug 04, 2025 | $156.98 | $134.94 | -14.04% |
May 06, 2025 | $162.29 | $139.47 | -14.06% |
Feb 19, 2025 | $156.69 | $176.17 | +12.43% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Krystal Biotech, Inc. (KRYS) report earnings?
Krystal Biotech, Inc. (KRYS) is schdueled to report earning on Mar 02, 2026, Before Open (Confirmed).
What is Krystal Biotech, Inc. (KRYS) earnings time?
Krystal Biotech, Inc. (KRYS) earnings time is at Mar 02, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is KRYS EPS forecast?
KRYS EPS forecast for the fiscal quarter 2025 (Q4) is 1.5.